Shin Nippon Biomedical Laboratories : MHLW Award of Excellence
December 03, 2018 at 06:22 am IST
Share
The Japanese Ministry of Health, Labour and Welfare (MHLW) gives annual awards to companies promoting equality in the workplace, and this year SNBL is one of two awardees of the MHLW's Award of Excellence. This award goes to companies that make exemplary efforts in proactively giving women the chance to demonstrate their ability, as well as supporting a good balance between career and child-rearing or caregiving. The official award ceremony will be held on January 16, 2019 in Tokyo.
SNBL is honored to receive this award and will continue providing a work environment in which equal opportunity can thrive, regardless of gender, race, age, disability, etc.
Attachments
Original document
Permalink
Disclaimer
Shin Nippon Biomedical Laboratories Ltd. published this content on 03 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 03 December 2018 00:51:04 UTC
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies. The Company has four business segments. The Preclinical segment is engaged in the verification of the effectiveness and safety of new drugs by conducting tests on experimental animals, cells and bacteria. The Clinical segment is engaged in the verification of the effectiveness and safety of test articles on human. The Translational Research segment is involved in the research and development of pharmaceutical products and related technology, as well as the conduction of preclinical and clinical trials, among others. The Others segment is engaged in information collecting business, the sale of environmental analysis equipment, and the operation of accommodation. As of March 31, 2013, the Company had 27 subsidiaries and one associated company.
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 
